SIRT1 and breast cancer: These observations not only cast doubts on the actual implication of HCAR2 in the beneficial effects of NAM against mammary tumors, but also argue against the involvement of sirtuin 1 (SIRT1) inhibition, which has been linked to the death of human BC cells exposed to high-dose NAM48.